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Introduction Prior upper body exercise reduces the curvature constant (W) of the hyperbolic 23 
power-duration relationship without affecting critical power. This study tested the hypothesis 24 
that prior upper body exercise reduces the work done over the end-test power (WEP; analogue 25 
of W) during a 3-min all-out cycling test (3MT) without affecting the end-test power (EP; 26 
analogue of critical power). Methods Ten endurance-trained men (V̇O2max = 62  5 mLkg
-27 
1min-1) performed a 3MT without (CYC) and with (ARM-CYC) prior severe-intensity, 28 
intermittent upper body exercise. EP was calculated as the mean power output over the last 30-29 
s of the 3MT, whereas WEP was calculated as the power-time integral above EP.  Results At 30 
the start of the 3MT, plasma [La-] (1.8  0.4 vs. 14.1  3.4 mmol·L-1) and [H+] (42.8  3.1 vs. 31 
58.6  5.5 nmol·L-1) were higher, whereas the strong ion difference ([SID]) (41.4  2.2 vs. 30.9 32 
 4.6 mmol·L-1) and [HCO3
-
] (27.0  1.9 vs. 16.9  3.2 mmol·L-1) were lower, during ARM-33 
CYC than CYC (P < 0.010). EP was 12% lower during the 3MT of ARM-CYC (298  52 W) 34 
than CYC (338  60 W) (P < 0.001), whereas WEP was not different (CYC: 12.8  3.3 kJ vs. 35 
ARM-CYC: 13.5  4.1 kJ, P = 0.312). EP in CYC was positively correlated with the peak [H+] 36 
(r = 0.78, P = 0008), and negatively correlated with the lowest [HCO3
-
] (r = -0.74, P = 0.015). 37 
Conclusion These results suggest that EP during a 3MT in endurance-trained men is sensitive 38 
to fatigue-related ionic perturbation.  39 







INTRODUCTION   45 
The hyperbolic power-duration relationship is conventionally determined using three to five 46 
constant power exercise tests lasting 2-15-min and performed until task failure (1,2). The 47 
asymptote of this relationship represents critical power (CP), whereas the curvature constant 48 
(termed W) represents a finite work capacity that is utilized when the power output exceeds 49 
CP (3). CP represents an important threshold of intramuscular metabolic control that defines 50 
the highest oxidative metabolic rate that can be sustained without utilization of W (3). Thus, 51 
CP demarcates the heavy and severe exercise intensity domains, with exercise <CP 52 
characterized by stability in intramuscular metabolism and pulmonary oxygen uptake (V̇O2), 53 
and exercise >CP characterized by inexorable metabolic perturbation and continued utilization 54 
of W (3,4). The determinants of W appear multifactorial and task specific (3). During whole-55 
body exercise the magnitude of W may be related to intramuscular energy stores ([PCr] and 56 




) (1,7,8) and the extent of associated muscle fatigue (4) and inefficiency 58 
(9,10).  59 
The power-duration relationship has great utility for those performing endurance and 60 
intermittent exercise (2,11), but the required number of exercise tests may deter some 61 
individuals. Therefore, a single 3-min all-out cycling test (3MT) was developed to expedite the 62 
estimation of CP and W (12). Hypothetically, the all-out nature of the 3MT results in complete 63 
depletion of W within 2-min. The mean power output over the final 30-s of the 3MT, termed 64 
end-test power (EP), estimates CP, whereas the work done above EP (WEP) estimates W (12). 65 
It is reported that EP and WEP are valid estimates of CP and W in recreationally active 66 
individuals (12,13) but not in trained cyclists (14,15). Furthermore, W and WEP do not always 67 
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correlate (13,16) and may respond differently to training (16), thus whether they are 68 
mechanistically equivalent remains uncertain.    69 
Insight into the mechanistic determinants of the power-duration relationship has been 70 
provided by studies using prior exercise to induce a pre-existing metabolic and ionic 71 
perturbation. Prior severe intensity cycling exercise followed by minimal recovery (2-min) 72 
reduced both W (-34–64%) and WEP (-21–45%) without affecting CP or EP (1,17,18). When 73 
prior exercise was followed by a 15-min recovery interval, WEP was fully restored (18), which 74 
suggests that the effects of prior exercise on WEP are sensitive to the intervening recovery 75 
duration. However, since prior exercise was performed using homologous muscles, reductions 76 
in W and WEP may have resulted from pre-existing intramuscular energy store depletion 77 
and/or metabolite and ionic perturbation. Interestingly, 2-h of heavy intensity cycling exercise 78 
reduced both EP (-11%) and WEP (-20%), which was not explained by pre-existing muscle 79 
glycogen depletion (19). Previously in the Journal, we reported on the effects of ionic 80 
perturbation, per se, on CP and W by preceding the constant power prediction trials with severe 81 
intensity upper body (arm-cranking) exercise (i.e. using non-homologous muscles) (8) which 82 
has the advantage of not concomitantly causing quadriceps muscle fatigue (20) or reducing leg 83 
intramuscular energy stores (21). Upper body exercise increased plasma [La-] and [H+] to 12 84 
mmolL-1 and 53 nmolL-1, respectively, accelerated plasma K+ accumulation during 85 
subsequent cycling exercise, and consistent with the effects of prior exercise using homologous 86 
muscles, reduced W by 32% without affecting CP (8).  87 
If EP and WEP are mechanistically equivalent to CP and W, it can be hypothesized 88 
that prior upper body exercise would reduce WEP without affecting EP. However, since the 89 
determinants of performance fatiguability are task specific (22), EP/WEP and CP/W may 90 
respond differently to interventions that modulate fatiguability and exercise tolerance. Indeed, 91 
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it is noteworthy that W was reduced (-22%) by mental fatigue (23) and increased (+26%) after 92 
creatine monohydrate supplementation (5), whereas WEP was unaffected (24,25).  93 
Therefore, the aim of this study was to examine the effects of prior severe intensity 94 
upper body exercise on the cycling 3MT in endurance-trained men. Based on the assumption 95 
that EP and WEP are mechanistically equivalent to CP and W, we tested the hypothesis that 96 
prior upper body exercise would reduce WEP without affecting EP.  97 
METHODS 98 
Participants and ethical approval 99 
Ten healthy, non-smoking men (age: 27  9 years; height: 178  8 cm; body mass: 73  8 kg) 100 
provided written informed consent to participate in the study. Participants included competitive 101 
(N = 6) and recreational (N = 2) cyclists, one competitive triathlete and one competitive middle-102 
distance runner. The study was approved by the institutional Human Ethics Committee and all 103 
procedures conformed to the standard set by the Declaration of Helsinki. 104 
Experimental design 105 
Participants attended the laboratory on seven separate occasions, at a similar time of day, 106 
separated by at least 48-h. During visit 1, participants performed a cycling ramp incremental 107 
test for determination of gas exchange threshold (GET) and V̇O2max. During visit 2, participants 108 
performed a 3MT, which served as a familiarization trial. During visits 3 and 4, participants 109 
performed a 3MT to evaluate the repeatability of EP and WEP. During visit 5, participants 110 
performed a 3MT preceded by severe-intensity upper body exercise, which served as a 111 
familiarization trial. During visits 6 and 7, participants performed in a randomized order a 3MT 112 
without and with prior severe-intensity upper body exercise (hereafter, these trials are termed 113 
CYC and ARM-CYC, respectively). Participants refrained from caffeine on test days, and 114 
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alcohol and strenuous exercise the day preceding and day of a test. Participants reported to the 115 
laboratory at least 2-h post-prandial.  116 
Equipment and measurements 117 
Exercise was performed using electromagnetically braked cycle (Excalibur Sport; Lode, 118 
Groningen, The Netherlands) and arm-cranking (Angio; Lode) ergometers. Participants fitted 119 
their own pedals to the cycle ergometer and the position of the seat and handlebars was 120 
replicated for all tests. Ventilatory and pulmonary gas exchange variables were measured 121 
breath-by-breath (ZAN 600USB CPX incorporating GPI V3.0 software; Nspire Health, 122 
Oberthulba, Germany). Participants wore a facemask (model 7940; Hans Rudolph, Missouri, 123 
USA) connected to a low resistance (0.51 cmH2OL
-1s-1 at <14 Ls-1) flow sensor (ZAN 124 
variable orifice pneumotach; Nspire Health) with a combined dead space of 67 mL. The flow 125 
sensor was calibrated using a 3-L syringe. Gas concentrations were sampled (50 mLmin-1) at 126 
the mouth via a 2-m capillary line and analyzed using fast responding laser diode absorption 127 
spectroscopy sensors that were calibrated using ambient air and gases of known concentration 128 
(5% CO2, 15% O2, balance N2; BOC, Guilford, UK). Volume and concentration signals were 129 
time aligned by accounting for the transit delay in the gas capillary line and the analyzer rise 130 
time (T10-90 <90-ms) relative to the volume signal.  131 
Heart rate was measured using short-range telemetry (Polar RS400; Polar Electro, Kempele, 132 
Finland). Arterial oxygen saturation (SpO2) was estimated using a pulse oximeter (Model 8500; 133 
Nonin Medical, Plymouth, MN) and an adhesive forehead reflectance sensor (Model 8000R; 134 
Nonin Medical). Arterialized venous blood (1.5-mL) was drawn from a heated dorsal hand vein 135 
using an indwelling 21-G cannula and a syringe containing dry electrolyte-balanced heparin 136 
(safePICO, Radiometer, Copenhagen, Denmark). Blood was analyzed immediately (ABL90 137 
FLEX; Radiometer) for [Hb] and pH, PCO2, [HCO3
-
], [K+], [Na+], [Ca2+], and [Cl-]. 0.5-mL of 138 
each blood sample was then immediately centrifuged for 10-min at 3000g. The plasma 139 
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supernatant was removed and analyzed for [La-] using enzymatic amperometry (Biosen C_Line 140 
Sport; EKF Diagnostics, Barleben, Germany), and total plasma protein concentration ([PPr–]) 141 
using colorimetry (Biuret method) (ABX Pentra 400; Horiba, Northampton, UK). The total 142 
concentration of weak acids ([Atot]) was calculated as 2.45  [PPr
–] (8). [H+] was derived from 143 
the measured pH as the antilog. The strong ion difference ([SID]) was calculated as the sum of 144 
the strong cations minus the sum of the strong anions: [SID] = ([Na+] + [K+] + [Ca2+]) – ([Cl-] 145 
+ [La-]) (8,26). This physicochemical approach to acid-base balance describes [H+] and 146 
[HCO3
-
] as dependent variables that are determined by the independent variables [SID], [Atot], 147 
and PCO2 (26). Changes in blood volume from baseline were calculated from changes in [Hb] 148 
(27).   149 
Cycling ramp incremental test 150 
Participants performed 3-min of unloaded cycling followed by an incremental ramp protocol 151 
(30 Wmin-1), at their preferred cadence, until the limit of tolerance or task failure (cadence 152 
below 60 rpm). Pulmonary gas exchange data were reduced to 10-s rolling averages. The GET 153 
was determined using the V-slope method and the V̇O2max was taken as the highest 10-s rolling 154 
average (28).   155 
The 3MT 156 
The 3MT was preceded by 3-min of unloaded cycling. During the last 3-s of unloaded cycling 157 
participants gradually increased their cadence so that maximum cadence was achieved at the 158 
start of the 3MT. Participants were instructed to maintain their cadence as high as possible for 159 
the duration of the 3MT. The resistance to pedaling was set using the linear mode of the cycle 160 
ergometer so that each participant reached a power output halfway between their GET and 161 
V̇O2max on reaching their preferred cadence (recorded during the ramp incremental test). Strong 162 
verbal encouragement was provided, and participants were blinded from the elapsed time to 163 
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prevent pacing. The EP was calculated as the mean power output over the last 30-s of the 3MT, 164 
whereas WEP was calculated as the power-time integral above EP (12). The  V̇O2max during 165 
the 3MT taken as the highest 10-s rolling average (28).  166 
Reliability of the 3MT 167 
Participants performed two 3MT (as described above) to evaluate the repeatability of EP and 168 
WEP. These tests included the same battery of measurements taken during CYC, although 169 
these data were not used for further analysis.  170 
CYC and ARM-CYC 171 
After 3-min of seated rest (baseline), participants remained seated and either rested for 11.5-172 
min (CYC) or performed severe-intensity, intermittent upper body exercise (ARM-CYC) 173 
comprising eight 1-min arm-cranking exercise intervals, interspersed by 30-s rest intervals, at 174 
an intensity of 1.5-2.0 Wkg-1 body mass (129  29 W) and cadence of 100-130 rpm (8,20). 175 
Seated rest / arm-cranking was followed by a 1-min rest interval during which participants 176 
transferred to the adjacent cycle ergometer. Thereafter, 3-min of unloaded cycling commenced 177 
followed by the 3MT. Blood samples were taken at baseline, at the start and end of the 3MT, 178 
and 3- and 6-min into recovery. Heart rate and SpO2 were measured at baseline and at the end 179 
of each arm-cranking exercise interval in ARM-CYC, or at an equivalent time point during 180 
CYC (latter data not reported). Thereafter, heart rate was measured every second during 181 
unloaded cycling and the 3MT, and SpO2 was measured every 30-s during the 3MT. The O2 182 
cost of exercise was determined using the V̇O2 gain (V̇O2/power) at 10-s intervals.   183 
Statistical analyses 184 
Normality of the data was confirmed by the Shiparo-Wilk test. For the reliability trials, EP and 185 
WEP were compared using Student’s paired t-tests. Trial-to-trial variation in EP and WEP was 186 
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calculated as the within-participant coefficient of variation (CV). Measurement error and 187 
repeatability of EP and WEP were calculated, along with the smallest meaningful change. 188 
Student’s paired t-tests were used to evaluate differences between CYC and ARM-CYC for 189 
peak power output and the corresponding cadence, time to peak power output, EP, WEP, and 190 
total work done during the 3MT. One-way repeated measures ANOVA followed by Tukey’s 191 
post-hoc test was used to evaluate differences in V̇O2max between the cycling ramp incremental 192 
test and the 3MT in CYC and ARM-CYC. For heart rate, ventilatory, and pulmonary gas 193 
exchange responses during the 3MT, data were averaged into 10-s bins. These data, along with 194 
SpO2, [Hb], and acid-base variables, were then analyzed using a two-way (trial  time) repeated 195 
measures ANOVA. Significant interactions and main effects were explored by determining 196 
between-trial differences at individual time-points using Student’s paired t-tests. Effect sizes 197 
are reported as partial eta-squared (
p
2) for ANOVA and Cohen’s dz for Student’s paired t-tests. 198 
The Pearson product moment correlation coefficient (r) was calculated to determine the 199 
relationship between selected variables. Statistical significance was set at P < 0.05. Data were 200 
analyzed using IBM SPSS Statistics V24.0, except for Cohen’s dz which was calculated using 201 
G*Power 3 software. Results are presented as mean  SD unless otherwise indicated.  202 
RESULTS 203 
Incremental cycling ramp test 204 
Peak power output was 419  73 W (5.7  0.5 Wkg-1), and V̇O2max was 4.53  0.65 Lmin
-1 205 
(62  5 mLkg-1min-1). The GET occurred at 2.82  0.52 Lmin-1 (240  44 W). The participants 206 
were therefore classified as ‘trained’ (V̇O2max between 55.0 – 64.9 mLkg
-1min-1) (n = 6) or 207 
‘well-trained’ (V̇O2max between 65.0 – 71.0 mLkg
-1min-1) (n = 4) (29).   208 
Reliability of the 3MT  209 
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There was no difference between the reliability trials for EP (328  53 vs. 337  57 W; t9 = 210 
1.42, P = 0.189, dz = 0.44) or WEP (13.1  4.4 vs. 13.3  2.9 kJ; t9 = 0.24, P = 0.820, dz = 0.07). 211 
For EP and WEP respectively, there was a day-to-day CV of 4% and 12%, measurement error 212 
of 14 W and 2.1 kJ, reproducibility of 40 W and 5.9 kJ, and a smallest meaningful change of 213 
20 W and 2.9 kJ.  214 
Peak power output, EP, WEP and total work done during 3MT of CYC and ARM-CYC 215 
Peak power output (t9 = 2.02, P = 0.074, dz = 0.62), the corresponding cadence (t9 = 2.03, P = 216 
0.073, dz = 0.53), and the time to peak power output (t9 = 0.52, P = 0.614, dz = 0.19) during the 217 
3MT were not different between CYC and ARM-CYC (Fig. 1), although a medium effect size 218 
was observed for peak power output. EP was 12% lower in ARM-CYC than CYC (mean 219 
difference = 40  13 W, 95% CI [31, 49 W]; t9 = 2.94, P < 0.001, dz = 3.07), whereas WEP 220 
was not different (t9 = 1.07, P = 0.312, dz = 0.34) (Fig. 1). The total work done was 9% lower 221 
in ARM-CYC (67.2  12.7 kJ) than CYC (73.7  13.7 kJ) (t9 = 7.34, P < 0.001, dz = 2.31). 222 
Cardiorespiratory responses during the 3MT of CYC and ARM-CYC 223 
Pulmonary gas exchange, heart rate and SpO2 responses are shown in Figure 2. For V̇O2, there 224 
was a trial × time interaction effect due to V̇O2 being 0.26 Lmin
-1 (5-7%) lower during ARM-225 
CYC than CYC over the final 50-s of the 3MT (t9 = 2.46 – 3.74, P = 0.005 – 0.036, dz = 0.77 – 226 
1.16). There was a main effect of test on V̇O2max (F2,18 = 9.20, P < 0.001, p
2  = 0.51). The 227 
V̇O2max during the cycling ramp incremental test and the 3MT of CYC (4.41  0.62 Lmin
-1) 228 
was not different (P = 0.549), whereas both were 5-8% higher than V̇O2max during the 3MT of 229 
ARM-CYC (4.17  0.64 Lmin-1) (P = 0.002 and 0.017, respectively). The relative reduction 230 
in V̇O2max  during ARM-CYC vs. CYC  was negatively correlated with the between-trial 231 
difference in peak [H+] (r = -0.86, P = 0.001). For the V̇O2 gain (Fig. 3), there was a trial  232 
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time interaction effect. The V̇O2 gain was 0.9 mLmin
-1W-1 (7%) higher during ARM-CYC 233 
than CYC at 130-s of the 3MT (t9 = 2.62, P = 0.028, dz = 0.83). V̇CO2 was 0.25 Lmin
-1 higher 234 
at the start of the 3MT in ARM-CYC than CYC (t9 = 2.77, P = 0.022, dz = 0.88). Thereafter, 235 
except for the first 30-s of the 3MT, V̇CO2 was 0.78 Lmin
-1 (15%) lower during ARM-236 
CYC than CYC (t9 = 3.55 – 6.11, P = <0.001 – 0.006, dz = 0.98 – 1.92). Heart rate was 9 237 
beatsmin-1 (6%) higher throughout the 3MT of ARM-CYC than CYC (t9 = 2.34 – 11.01, P = 238 
<0.001 – 0.044, dz = 0.73 – 3.54). SpO2 fell during the 3MT and was 2% lower during ARM-239 
CYC than CYC after 150-s (t9 = 2.51, P = 0.033, dz = 0.79) and 180-s (t9 = 2.41, P = 0.039, dz 240 
= 0.76).  241 
Ventilatory responses during the 3MT of CYC and ARM-CYC 242 
Ventilatory response are shown in Figure 4. For V̇E, the trial × time interaction effect was due 243 
to an 19 Lmin-1 higher V̇E during ARM-CYC than CYC at the start (t9 = 3.89, P = 0.003, dz 244 
= 1.24) and after 10-s (t9 = 2.99, P = 0.015, dz = 0.94) of the 3MT. Thereafter, V̇E was similar 245 
between CYC and ARM-CYC, although a relative tachypnea (i.e. lower VT and higher fR) was 246 
observed in ARM-CYC. Due to V̇E being higher at the start of the 3MT of ARM-CYC than 247 
CYC, V̇E/V̇O2 was also higher by 8 (t9 = 5.30, P < 0.001, dz = 1.67). Conversely, the higher 248 
V̇E/V̇O2 during ARM-CYC than CYC from 110-180-s of the 3MT (t9 = 2.35 – 6.19, P = <0.001 249 
– 0.043, dz = 0.74 – 1.98) was due to the lower V̇O2 in ARM-CYC. The lower V̇CO2 during 250 
the 3MT of ARM-CYC resulted in V̇E/V̇CO2 being higher during ARM-CYC than CYC (t9  251 
3.27 – 8.60, P = <0.001 – 0.009, dz = 1.02 – 2.44). PETCO2 was 6 mmHg (17%) lower 252 
throughout the 3MT of ARM-CYC than CYC (t9 = 3.40 – 9.26, P = <0.001 – 0.008, dz = 0.96 253 
– 2.74).  254 
Blood volume and plasma acid-base balance during CYC and ARM-CYC 255 
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During the 3MT of CYC blood volume fell by 8%, as reflected by the 1.4  0.3 gdL-1 increase 256 
in [Hb] from baseline (Table 1). The 3MT of ARM-CYC commenced with a pre-existing 8% 257 
reduction in blood volume from baseline, as reflected by the 1.3  0.2 gdL-1 increase in [Hb]. 258 
A further reduction in blood volume (12% from baseline) was observed at the end of the 3MT 259 
in ARM-CYC, as reflected by a further 0.8  0.2 gdL-1 increase in [Hb]. The greater [Hb] at 260 
the start (t9 = 6.74, P < 0.001, dz = 2.12) and end (t9 = 3.51, P = 0.007, dz = 1.14) of the 3MT 261 
of ARM-CYC than CYC reflects a lower blood volume during ARM-CYC.   262 
Plasma acid-base variables at baseline were not different between CYC and ARM-CYC 263 
and therefore these data were pooled (Table 1). The [La-], [Na+], [Cl-], and [PPr-] were higher 264 
at the start and end of the 3MT of ARM-CYC than CYC. The net increase in [La-] during the 265 
3MT was smaller during ARM-CYC (7.8  4.0 mmolL-1) than CYC (13.2  3.5 mmolL-1) (t9 266 
= 4.51, P = 0.001, dz = 1.42). The between-trial differences in ion concentrations and [PPr
-] 267 
resulted in between-trial differences for the independent acid-base variables [SID] and [Atot]. 268 
Specifically, [SID] was lower during ARM-CYC than CYC at the start (-10.5 mmolL
-1) and 269 
end (-5.2 mmolL-1) of the 3MT, whereas [Atot] was higher during ARM-CYC than CYC at 270 
the start (2.3 mmolL-1) and end (1.4 mmolL-1) of the 3MT. PCO2 was 12.0-13.0 mmHg 271 
lower during ARM-CYC than CYC at the start and end of the 3MT. The between-trial 272 
differences in the independent acid-base variables resulted in between-trial differences in the 273 
dependent acid-base variables [H+] and [HCO3
-
]. Specifically, [H+] was higher and [HCO3
-
] was 274 
lower during ARM-CYC than CYC at the start (15.8 nmolL-1 and -10.1 mmolL-1) and end 275 
(10.4 nmolL-1 and -4.0 mmolL-1) of the 3MT. The net increase in [H+] during the 3MT was 276 
smaller during ARM-CYC (22.6  10.2 nmolL-1) than CYC (28.0  10.6 nmolL-1) (t9 = 3.43, 277 
P = 0.008, dz = 1.06).  278 
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The EP and WEP (normalized to body mass) in CYC were positively correlated with 279 
the peak [H+], and negatively correlated with the lowest  (Fig. 5).  280 
DISCUSSION 281 
Main findings 282 
In contrast to our hypothesis, the main finding of the present study was that prior upper body 283 
exercise, which caused marked pre-existing ionic perturbation, reduced EP by 12% (40 W) 284 
without affecting WEP. Importantly, the 40 W reduction in EP and the associated true score 285 
change 95% CI exceeded the smallest meaningful change (20 W). Moreover, the EP in CYC 286 
was correlated with the dependent acid-base variables, namely peak [H+] and minimum287 
. These novel observations are the first to suggest that EP during the 3MT is sensitive 288 
to fatigue-related ionic perturbation.  289 
Prior upper body exercise and the power-duration relationship: 3MT vs. conventional 290 
protocol 291 
Previously in the Journal we showed that prior severe intensity upper body exercise reduced 292 
W by 32% without affecting CP (8). We therefore examined the effects of an identical prior 293 
upper body exercise protocol, causing comparable pre-existing ionic perturbation, on EP (the 294 
analogue of CP) and WEP (the analogue of W) to test the hypothesis that these parameters are 295 
mechanistically equivalent to CP and W. In stark contrast to this hypothesis, prior upper body 296 
exercise reduced EP without affecting WEP. This suggests that EP and WEP are not 297 
mechanistically equivalent to CP and W. Moreover, these discrepancies suggest that the 298 
determinants of EP and WEP are specific to the 3MT and, in part, different from the 299 
determinants of CP and W established using severe intensity constant power exercise. 300 





explain why the parameter estimates are task specific, including: (1) type of exercise test (all-302 
out closed-end vs. constant power open-end); (2) test duration (3-min vs. 3-15-min); (3) 303 
ergometer mode (linear vs. hyperbolic), which dictates power and cadence profiles and 304 
therefore power-velocity relationships; and (4) different exercise intensity domains (extreme 305 
and severe domains vs. severe domain only), which mediates intramuscular metabolic 306 
perturbation (4,28). By applying the EP and WEP measured in CYC to the hyperbolic power-307 
duration model, the lower boundary of the extreme domain (i.e. the power output eliciting task 308 
failure in 120-s) can be estimated at 445  85 W. Participants therefore spent the first 36  4 s 309 
(20%) of the 3MT in the extreme domain, which may explain why plasma [H+] at the end of 310 
the 3MT was 10 nmol·L-1 (16%) greater than that previously observed at task failure during 311 
severe intensity constant power cycling exercise (8). The significance of performing extreme 312 
intensity exercise initially during the 3MT remains uncertain and warrants further investigation. 313 
Importantly, participants spent the latter ~80% of the 3MT in the severe intensity domain, 314 
which suggests the mechanisms by which prior upper body exercise reduces EP are related to 315 
changes in the physiology of severe intensity exercise. Moreover, from a practical perspective, 316 
the findings of the present study suggest that if sport and exercise science practitioners use the 317 
3MT for athlete evaluation, especially if it is part of a testing battery, it should be performed in 318 
a ‘fresh’ state to ensure that test validity is not compromised and to avoid underestimating CP. 319 
Prior exercise and the power-duration relationship: homologous vs. non-homologous 320 
muscles 321 
The findings of the present study, along with those of Johnson et al. (8), show that prior exercise 322 
using non-homologous muscles reduces EP and W without affecting CP or WEP. Interestingly, 323 
prior exercise using homologous muscles reduces both W and WEP without affecting CP or 324 
EP (1,17,18). Previous studies preceded the 3MT with 4-min of severe intensity cycling 325 
exercise (17) or a 30-s all-out cycling sprint followed by 2-min recovery (18). At the start of 326 
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the 3MT blood [La-] was 3.7 (17) and 5.6 mmol·L-1 (18) and WEP was reduced by 45% (17) 327 
and 21% (18). However, when prior exercise was followed by 15-min recovery and thus 328 
probable replenishment of intramuscular [PCr], WEP was fully restored despite the 3MT 329 
commencing with blood [La-] at 5.5 mmol·L-1 (18). This suggests that WEP is mediated more 330 
by intramuscular [PCr] than ionic / metabolite perturbation. This may explain why WEP was 331 
not reduced in ARM-CYC since upper-body exercise does not concomitantly reduce leg 332 
intramuscular [PCr] (21).   333 
The mechanisms by which EP is reduced by prior exercise using non-homologous, but 334 
not homologous, muscles remain unclear. Possible explanations include between-study 335 
differences in: (1) the magnitude of ionic / metabolite perturbation incurred; (2) peripheral and 336 
/ or central fatigue kinetics; and/or (3) participant training status which may affect the validity 337 
of the 3MT. In the present study, WEP was similar to previous reports in trained cyclists (11-338 
15 kJ) (14,15,30), but notably lower than W (20-30 kJ) (2,15,23). In trained cyclists, EP may 339 
overestimate CP by 11-15%, whereas WEP may underestimate W by 36-45% (14,15). These 340 
studies raise the possibility that W is still being expended during the final 30-s of the 3MT, 341 
which results in EP being elevated at the expense of WEP. It is therefore possible that a 342 
reduction in EP after prior upper body exercise reflects, in part, a reduction in W. However, 343 
evaluating the validity of the 3MT requires 3-5 additional tests to derive CP and W, which was 344 
beyond the scope of the present study.  345 
Why does prior upper body exercise reduce EP? 346 
The finding that EP is reduced after prior upper body exercise suggests that EP is partly 347 
determined by ionic perturbation. This is also supported by the observation that EP correlated 348 
positively with the peak [H+], and negatively with the lowest [HCO3
-
] . Prior upper body 349 
exercise may have therefore reduced EP by affecting intramuscular ionic perturbation. 350 
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Specifically, during the 3MT of ARM-CYC the fall in leg intramuscular [SID] and concomitant 351 
increase in [H+] may have proceeded at a faster rate (21) due to: (I) reduced La- efflux from 352 
locomotor muscles due to high plasma [La-] and [H+] (21) and low plasma [HCO3
-
] (31); (II) 353 
reduced La- removal from the blood due to La- accumulation in upper body muscle and other 354 
tissues; and (III) greater K+ release from locomotor muscles (8,21) due to an acidosis-mediated 355 
increase in the opening probability of ATP-sensitive K+ channels (32). Increased interstitial 356 
[K+] and/or intramuscular [H+], which exacerbates the fatiguing effects of Pi by increasing 357 
[H2PO4
-], may have accelerated the development of peripheral locomotor muscle fatigue (33) 358 
during the 3MT of ARM-CYC. Although objective fatigue measurements were not taken in 359 
the present study, the higher V̇O2 gain during the 3MT of ARM-CYC than CYC may reflect 360 
differences in muscle bioenergetics and peripheral fatigue development (9).  361 
The ionic perturbation induced by prior upper body exercise may have also reduced EP 362 
by exacerbating central fatigue. This is consistent with the observation that central fatigue 363 
develops more quickly during severe intensity constant power cycling exercise preceded by 364 
upper body exercise (20). Incidentally, central fatigue may manifest within the first 30-s of the 365 
3MT (34), which differs from severe intensity constant power exercise (i.e. the conventional 366 
protocol) where central fatigue manifests largely towards the end of exercise (35). At the start 367 
of the 3MT in ARM-CYC, the ensemble group III/IV muscle afferent feedback, mediated by 368 
intramuscular metabolic / ionic perturbation, may have been elevated due to pre-existing 369 
afferent feedback originating mainly from upper body muscles (20). Increased central 370 
projection of group III/IV muscle afferents provides inhibitory feedback to the central nervous 371 
system, thereby reducing and/or confining central motor drive (36). This may therefore explain, 372 
in part, the reduced EP after prior upper body exercise in the present study.  373 
A limitation of the present study is that we did not validate our previous finding that 374 
prior upper body exercise reduces the conventionally determined W without affecting CP (8). 375 
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However, this would have required an additional 8-10 tests to establish the hyperbolic power-376 
duration relationship with and without prior upper body exercise, which was beyond the scope 377 
of the present study. It is therefore possible that, in the present cohort, the reduced EP and 378 
unchanged WEP after prior upper body exercise reflects a reduced CP and unchanged W. 379 
However, we consider this unlikely for three reasons: (I) one participant was common to both 380 
studies, and despite their training status being strikingly similar on both occasions (V̇O2max = 381 
61 vs. 62 mLkg-1min-1; GET = 3.08 vs. 3.00 Lmin-1) they experienced, after prior upper body 382 
exercise, marked falls in W (CYC vs. ARM-CYC: 16.1 vs. 11.1 kJ) and EP (351 vs. 304 W) 383 
but not CP (279 vs. 281 W) or WEP (12.4 vs. 14.4 kJ); (II) if, in the present cohort, the reduced 384 
EP after prior upper body exercise reflects a reduced CP, this would indicate that the 385 
mechanistic bases of CP differ from our previous cohort, which seems unlikely given the well-386 
established mechanistic bases of CP in healthy humans (3); and (III) it is improbable that the 387 
mechanistic bases of CP and W in the present cohort would differ sufficiently from our 388 
previous cohort (8) to elicit contrasting effects of prior upper body exercise on CP and W. 389 
Based on these considerations, it is likely that our previous observations (8) can be generalized 390 
to the present cohort.   391 
Effects of prior upper body exercise on peak power output and V̇O2max during the 3MT 392 
Peak power output during the 3MT was not statistically different between CYC and ARM-393 
CYC, although the effect size was medium. Interestingly, peak power output during a 30-s 394 
cycling sprint was unchanged after prior arm-cranking exercise that increased blood [La-] to 395 
11.0 mmoL·L-1 (37) whereas it was reduced by 5% after four sets of prior biceps curls that 396 
increased blood [La-] by only 2.0 mmol·L-1 (38). Reduced peak cycling power output after 397 
prior upper body exercise may thus result from a reduced upper body contribution to peak 398 
power output (38), rather than the degree of pre-existing ionic / metabolite perturbation per se.  399 
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In the present study, prior upper body exercise increased maximal heart rate but reduced 400 
V̇O2max during the 3MT. An identical prior upper body exercise protocol reduced both V̇O2max 401 
and maximal heart rate during an incremental cycling test (8). Conversely, prior exercise using 402 
homologous muscles did not affect V̇O2max during subsequent severe intensity constant power 403 
exercise (1), or V̇O2max and maximal heart rate during the 3MT (17–19). This suggests that 404 
autonomic function and V̇O2max are affected differently by prior exercise using homologous 405 
and non-homologous muscles. Interestingly, the reduced V̇O2max during ARM-CYC correlated 406 
negatively with the between-trial difference in peak [H+]. Greater acidosis during ARM-CYC 407 
may have reduced V̇O2max by inhibiting oxidative phosphorylation (39) and / or by reducing 408 
SpO2 (due to a rightward shift in the HbO2 dissociation curve) and thereby convective oxygen 409 
transport (26). Our SpO2 data (Fig. 2D) support that oxygen delivery was reduced after prior 410 
upper body exercise, although some caution is warranted given the limitations associated with 411 
estimating SpO2 using pulse oximetry (26). Nevertheless, for two reasons, it seems most likely 412 
that compromised convective oxygen transport primarily explains the lower V̇O2max in ARM-413 
CYC: (I) V̇O2max  in endurance-trained individuals is limited by oxygen supply rather than 414 
mitochondrial respiration (40); and (II) V̇O2max is still reached during consecutive maximal 415 
cycling exercise bouts even when intramuscular acidification is increased using bilateral leg 416 
occlusion during the intervening recovery periods (41). The lower blood volume during the 417 
3MT of ARM-CYC than CYC, which reflects greater plasma volume shifts from vascular to 418 
intracellular compartments (26), may have also reduced stroke volume, which if not 419 
compensated by the higher heart rate may have compromised cardiac output and locomotor 420 
muscle perfusion. Persistent sympathetic vasoconstrictor outflow secondary to continued group 421 
III/IV afferent activity originating in fatigued respiratory (evidenced by the tachypnoeic 422 
breathing pattern, Fig. 4B and C) and upper body muscles may have also compromised 423 
locomotor muscle perfusion. However, whether the reduced V̇O2max per se contributed to the 424 
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lower EP remains uncertain since between-trial differences in power output preceded 425 
differences in V̇O2. 426 
Conclusion 427 
In conclusion, the EP derived during a 3MT was reduced by prior severe intensity upper body 428 
exercise and correlated with markers of ionic perturbation. These findings therefore suggest 429 
that EP is sensitive to fatigue-related ionic perturbation in endurance trained men. Since the 430 
results of the present study contrast the effects of prior upper body exercise on the 431 
conventionally determined CP and W, it is possible that EP and WEP are not mechanistically 432 
equivalent to CP and W. These findings have important implications for future studies using 433 
the 3MT as a framework to investigate fatigue mechanisms and the effects of experimental 434 
intervention.  435 
Acknowledgements 436 
None 437 
Conflict of Interest  438 
The results of the present study do not constitute endorsement by ACSM. 439 
The results of the study are presented clearly, honestly, and without fabrication, falsification, 440 









1.  Ferguson C, Whipp BJ, Cathcart AJ, Rossiter HB, Turner AP, Ward SA. Effects of prior 448 
very-heavy intensity exercise on indices of aerobic function and high-intensity exercise 449 
tolerance. J Appl Physiol. 2007;103(3):812–22.  450 
2.  Johnson MA, Sharpe GR, Brown PI. Inspiratory muscle training improves cycling time-451 
trial performance and anaerobic work capacity but not critical power. Eur J Appl Physiol. 452 
2007;101(6):761–70.  453 
3.  Poole DC, Burnley M, Vanhatalo A, Rossiter HB, Jones AM. Critical power: An 454 
important fatigue threshold in exercise physiology. Med Sci Sports Exerc. 455 
2016;48(11):2320–34.  456 
4.  Burnley M, Jones AM. Power-duration relationship: Physiology, fatigue, and the limits 457 
of human performance. Eur J Sport Sci. 2018;18(1):1–12.  458 
5.  Miura A, Kino F, Kajitani S, Sato H, Fukuba Y. The effect of oral creatine 459 
supplementation on the curvature constant parameter of the power-duration curve for 460 
cycle ergometry in humans. Jpn J Physiol. 1999;49(2):169–74.  461 
6.  Miura A, Sato H, Sato H, Whipp BJ, Fukuba Y. The effect of glycogen depletion on the 462 
curvature constant parameter of the power-duration curve for cycle ergometry. 463 
Ergonomics. 2000;43(1):133–41.  464 
7.  Green S, Dawson BT, Goodman C, Carey MF. Y-intercept of the maximal work-duration 465 
relationship and anaerobic capacity in cyclists. Eur J Appl Physiol Occup Physiol. 466 
1994;69(6):550–6.  467 
8.  Johnson MA, Mills DE, Brown PI, Sharpe GR. Prior upper body exercise reduces cycling 468 
work capacity but not critical power. Med Sci Sports Exerc. 2014;46(4):802–8.  469 
9.  Grassi B, Rossiter HB, Zoladz JA. Skeletal muscle fatigue and decreased efficiency: two 470 
sides of the same coin? Exerc Sport Sci Rev. 2015;43(2):75–83.  471 
10.  Vanhatalo A, Poole DC, DiMenna FJ, Bailey SJ, Jones AM. Muscle fiber recruitment and 472 
the slow component of O2 uptake: constant work rate vs. all-out sprint exercise. Am J 473 
Physiol Regul Integr Comp Physiol. 2011;300(3):R700-707.  474 
11.  Jones AM, Vanhatalo A. The “Critical Power” concept: Applications to sports 475 
performance with a focus on intermittent high-intensity exercise. Sports Med. 476 
2017;47(Suppl 1):65–78.  477 
12.  Vanhatalo A, Doust JH, Burnley M. Determination of critical power using a 3-min all-478 
out cycling test. Med Sci Sports Exerc. 2007;39(3):548–55.  479 
13.  Simpson LP, Jones AM, Skiba PF, Vanhatalo A, Wilkerson D. Influence of hypoxia on 480 
the power-duration relationship during high-intensity exercise. Int J Sports Med. 481 
2015;36(2):113–9.  482 
21 
 
14.  Bartram JC, Thewlis D, Martin DT, Norton KI. Predicting critical power in elite cyclists: 483 
Questioning the validity of the 3-minute all-out test. Int J Sports Physiol Perform. 484 
2017;12(6):783–7.  485 
15.  Wright J, Bruce-Low S, Jobson SA. The 3-minute all-out cycling test is sensitive to 486 
changes in cadence using the Lode Excalibur Sport ergometer. J Sports Sci. 487 
2019;37(2):156–62.  488 
16.  Vanhatalo A, Doust JH, Burnley M. A 3-min all-out cycling test is sensitive to a change 489 
in critical power. Med Sci Sports Exerc. 2008;40(9):1693–9.  490 
17.  Parker Simpson L, Jones AM, Vanhatalo A, Wilkerson DP. Influence of initial metabolic 491 
rate on the power-duration relationship for all-out exercise. Eur J Appl Physiol. 492 
2012;112(7):2467–73.  493 
18.  Vanhatalo A, Jones AM. Influence of prior sprint exercise on the parameters of the “all-494 
out critical power test” in men. Exp Physiol. 2009;94(2):255–63.  495 
19.  Clark IE, Vanhatalo A, Thompson C, Wylie LJ, Bailey SJ, Kirby BS, Wilkins BW, Jones 496 
AM. Changes in the power-duration relationship following prolonged exercise: 497 
estimation using conventional and all-out protocols and relationship with muscle 498 
glycogen. Am J Physiol Regul Integr Comp Physiol. 2019;317(1):R59–67.  499 
20.  Johnson MA, Sharpe GR, Williams NC, Hannah R. Locomotor muscle fatigue is not 500 
critically regulated after prior upper body exercise. J Appl Physiol. 2015;119(7):840–50.  501 
21.  Bangsbo J, Madsen K, Kiens B, Richter EA. Effect of muscle acidity on muscle 502 
metabolism and fatigue during intense exercise in man. J Physiol. 1996;495(Pt 2):587–503 
96.  504 
22.  Thomas K, Goodall S, Howatson G. Performance fatigability is not regulated to a 505 
peripheral critical threshold. Exerc Sport Sci Rev. 2018;46(4):240–6.  506 
23.  Salam H, Marcora SM, Hopker JG. The effect of mental fatigue on critical power during 507 
cycling exercise. Eur J Appl Physiol. 2018;118(1):85–92.  508 
24.  Martin K, Thompson KG, Keegan R, Ball N, Rattray B. Mental fatigue does not affect 509 
maximal anaerobic exercise performance. Eur J Appl Physiol. 2015;115(4):715–25.  510 
25.  Vanhatalo A, Jones AM. Influence of creatine supplementation on the parameters of the 511 
“all-out critical power test.” J Exerc Sci Fit. 2009;7(1):9–17.  512 
26.  Stickland MK, Lindinger MI, Olfert IM, Heigenhauser GJF, Hopkins SR. Pulmonary gas 513 
exchange and acid-base balance during exercise. Compr Physiol. 2013;3(2):693–739.  514 
27.  Harrison MH. Effects on thermal stress and exercise on blood volume in humans. Physiol 515 
Rev. 1985;65(1):149–209.  516 
28.  Vanhatalo A, Black MI, DiMenna FJ, Blackwell JR, Schmidt JF, Thompson C, Wylie LJ, 517 
Mohr M, Bangsbo J, Krustrup P, Jones AM. The mechanistic bases of the power-time 518 
relationship: muscle metabolic responses and relationships to muscle fibre type. J Physiol. 519 
2016;594(15):4407–23.  520 
22 
 
29.  De Pauw K, Roelands B, Cheung SS, de Geus B, Rietjens G, Meeusen R. Guidelines to 521 
classify subject groups in sport-science research. Int J Sports Physiol Perform. 522 
2013;8(2):111–22.  523 
30.  McClave SA, LeBlanc M, Hawkins SA. Sustainability of critical power determined by a 524 
3-minute all-out test in elite cyclists. J Strength Cond Res. 2011;25(11):3093–8.  525 
31.  Mainwood GW, Worsley-Brown P. The effects of extracellular pH and buffer 526 
concentration on the efflux of lactate from frog sartorius muscle. J Physiol. 527 
1975;250(1):1–22.  528 
32.  Davies NW. Modulation of ATP-sensitive K+ channels in skeletal muscle by intracellular 529 
protons. Nature. 1990;343(6256):375–7.  530 
33.  Kent-Braun JA, Fitts RH, Christie A. Skeletal muscle fatigue. Compr Physiol. 531 
2012;2(2):997–1044.  532 
34.  Fernandez-del-Olmo M, Rodriguez FA, Marquez G, Iglesias X, Marina M, Benitez A, 533 
Vallejo L, Acero RM. Isometric knee extensor fatigue following a Wingate test: 534 
peripheral and central mechanisms. Scand J Med Sci Sports. 2013;23(1):57–65.  535 
35.  Decorte N, Lafaix PA, Millet GY, Wuyam B, Verges S. Central and peripheral fatigue 536 
kinetics during exhaustive constant-load cycling. Scand J Med Sci Sports. 537 
2012;22(3):381–91.  538 
36.  Amann M, Sidhu SK, Weavil JC, Mangum TS, Venturelli M. Autonomic responses to 539 
exercise: group III/IV muscle afferents and fatigue. Auton Neurosci. 2015;188:19–23.  540 
37.  Bogdanis GC, Nevill ME, Lakomy HK. Effects of previous dynamic arm exercise on 541 
power output during repeated maximal sprint cycling. J Sports Sci. 1994;12(4):363–70.  542 
38.  Grant MC, Robergs R, Baird MF, Baker JS. The effect of prior upper body exercise on 543 
subsequent wingate performance. Biomed Res Int. 2014;329328.  544 
39.  Jubrias SA, Crowther GJ, Shankland EG, Gronka RK, Conley KE. Acidosis inhibits 545 
oxidative phosphorylation in contracting human skeletal muscle in vivo. J Physiol. 546 
2003;553(Pt 2):589–99.  547 
40.  Gifford JR, Garten RS, Nelson AD, Trinity JD, Layec G, Witman MAH, et al. 548 
Symmorphosis and skeletal muscle V̇O2max: in vivo and in vitro measures reveal differing 549 
constraints in the exercise-trained and untrained human. J Physiol. 2016;594(6):1741–51.  550 
41.  Morales-Alamo D, Losa-Reyna J, Torres-Peralta R, Martin-Rincon M, Perez-Valera M, 551 
Curtelin D, Ponce-González JG, Santana A, Calbet JAL. What limits performance during 552 
whole-body incremental exercise to exhaustion in humans? J Physiol. 553 





FIGURE 1 – Power profiles (A), end-test power output (EP) (B), and work done above end-557 
test power output (WEP) (C) during the 3MT of CYC and ARM-CYC. Data in A are mean 558 
with error bars omitted to enhance clarity. Data in B and C are mean  SD, with lines 559 






FIGURE 2 – Pulmonary oxygen uptake (V̇O2) (A), carbon dioxide production (V̇CO2 ) (B), 564 
heart rate (C), and arterial oxygen saturation by pulse oximetry (SpO2) (D) during the 3MT of 565 
CYC and ARM-CYC. Panels A-C also show the final 30-s of unloaded cycling, with the 3MT 566 
commencing at time 0-s. Data are mean  SD. *Difference between trials (P < 0.05). Capped 567 
lines with asterix denote the range of measurement points that differ between CYC and ARM-568 




FIGURE 3 – Pulmonary oxygen uptake (V̇O2) gain during the 3MT of CYC and ARM-CYC. 573 





















FIGURE 4 – Minute ventilation (V̇E) (A), tidal volume (VT) (B), breathing frequency (fR) (C), 593 
ventilatory equivalents for oxygen (V̇E/V̇O2) (D) and carbon dioxide (V̇E/V̇CO2) (E), and end-594 
tidal CO2 (PETCO2) (F) during the 3MT of CYC and ARM-CYC. The final 30-s of unloaded 595 
cycling is also shown, with the 3MT commencing at time 0-s. Data are mean  SD. *Difference 596 
between trials (P < 0.05). Capped lines with asterix denote the range of measurement points 597 








FIGURE 5 – Correlations between end-test power (EP) and peak [H+] (A), EP and lowest 604 
 (B), work done above EP (WEP) and peak [H+] (C), and WEP and lowest  605 
(D).  606 
 607 
TABLE 1 [Hb] and plasma acid-base variables at baseline (pooled data), at the start and end of the 3MT, and 608 
after 3- and 6-min recovery. ∆Blood volume represents the percentage change from baseline. Values are mean  609 
SD.  610 
 
Baseline 
Start of 3-min test End of 3-min test 3-min recovery 6-min recovery 
 CYC ARM-CYC CYC ARM-CYC CYC ARM-CYC CYC ARM-CYC 
[Hb] (gdL-1)#†‡ 14.9  0.7 15.2  0.7 16.2  0.7** 16.3  0.9 17.0  0.7* 16.3  0.8 16.5  0.8 16.1  0.7 16.1  0.7 
∆Blood volume (%)  -1.5  1.4 -8.1  1.3 -8.3  1.6 -12.5  1.1 -8.1  1.3 -9.5  1.0 -6.8  1.1 -7.7  1.2 
Ions and [PPr-]     
[La-] (mmolL-1)#†‡ 1.3  0.3 1.8  0.4 14.1  3.4** 15.0  3.7 21.9  4.2** 21.7  4.2 23.6  3.2* 20.3  4.1 21.8  3.3 
[Na+] (mmolL-1)#†‡ 141  1 142  1 145  2** 147  2 150  2** 146  2 147  2 144  1 145  1 
[K+] (mmolL-1)† 3.9  0.2 4.1  0.2 3.9  0.2 5.1  0.4 5.1  0.5 3.8  0.2 3.8  0.2 3.7  0.3 3.7  0.2 
[Ca2+] (mmolL-1)†‡ 1.2  0.4 1.2  0.0 1.3  0.0 1.3  0.1 1.3  0.1 1.3  0.1 1.3  0.1 1.3  0.1 1.3  0.1 
[Cl-] (mmolL-1)†‡ 104  2 103  2 105  3* 106  3 108  2** 105  2 106  1 105  2 105  1 
[PPr-] (gdL-1)#†‡ 7.4  0.4 7.4  0.3 8.3  0.4** 8.5  0.4 9.1  0.5* 8.4  0.4 8.8  0.5 8.2  0.6 8.5  0.6 
Independent acid-base variables     
[SID] (mmolL-1)#†‡ 40.4  1.6 41.4  2.2 30.9  4.6** 33.3  3.2 28.0  4.0** 25.5  2.9 24.1  3.3* 25.5  3.1 24.2  3.2* 
[Atot] (mmolL-1)#†‡ 18.2  1.0 18.1  0.7 20.4  1.1** 20.8  1.1 22.2  1.2* 20.7  1.1 21.5  1.2 20.2  1.4 20.9  1.4 
PCO2 (mmHg)#†‡ 42.1  3.4 51.7  5.9 40.1  8.0** 57.6  8.7 44.8  10.3** 39.0  4.1 34.4  5.2** 38.8  4.8 34.1  3.3** 
Dependent acid-base variables     
[H+] (nmolL-1)#†‡ 38.0  1.7 42.8  3.1 58.6  5.5** 70.8  12.4 81.2  13.5** 81.3  14.2 86.5  14.0* 79.2  14.7 82.4  14.2 
[HCO3
-
] (mmolL-1)#†‡ 26.6  1.3 27.0  1.9 16.9  3.2** 17.1  2.5 13.1  2.4** 12.5  1.9 11.3  1.9** 12.8  2.3 11.7  2.1** 
# Main effect of trial (P = <0.001 – 0.042, 
p
2  = 0.39 – 0.90); † main effect of time (P < 0.001, 
p
2  = 0.70 – 0.97); 611 
‡ trial × time interaction (P  0.001, 
p
2  = 0.47 – 0.93). Different from equivalent CYC value: *P < 0.05, **P < 612 
0.01. 613 
][HCO-3 ][HCO
-
3
